APO866 activity in hematologic malignancies: a preclinical in vitro study

被引:23
作者
Cea, Michele [1 ]
Zoppoli, Gabriele [1 ]
Bruzzone, Santina [1 ]
Fruscione, Floriana [1 ]
Moran, Eva [1 ]
Garuti, Anna [1 ]
Rocco, Ilaria [1 ]
Cirmena, Gabriella [1 ]
Casciaro, Salvatore [1 ]
Olcese, Francesca [1 ]
Pierri, Ivana [1 ]
Cagnetta, Antonia [1 ]
Ferrando, Fabio [1 ]
Ghio, Riccardo [1 ]
Gobbi, Marco [1 ]
Ballestrero, Alberto [1 ]
Patrone, Franco [1 ]
Nencioni, Alessio [1 ]
机构
[1] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy
关键词
INHIBITOR;
D O I
10.1182/blood-2009-03-209213
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:6035 / 6037
页数:3
相关论文
共 5 条
  • [1] Extracellular NAD+ regulates intracellular calcium levels and induces activation of human granulocytes
    Bruzzone, S
    Moreschi, I
    Guida, L
    Usai, C
    Zocchi, E
    De Flora, A
    [J]. BIOCHEMICAL JOURNAL, 2006, 393 (697-704) : 697 - 704
  • [2] Hasmann M, 2003, CANCER RES, V63, P7436
  • [3] The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies
    Nahimana, Aimable
    Attinger, Antoine
    Aubry, Dominique
    Greaney, Peter
    Ireson, Christopher
    Thougaard, Annemette V.
    Tjornelund, Jette
    Dawson, Keith M.
    Dupuis, Marc
    Duchosal, Michel A.
    [J]. BLOOD, 2009, 113 (14) : 3276 - 3286
  • [4] Sulforhodamine B colorimetric assay for cytotoxicity screening
    Vichai, Vanicha
    Kirtikara, Kanyawim
    [J]. NATURE PROTOCOLS, 2006, 1 (03) : 1112 - 1116
  • [5] VISTICA DT, 1991, CANCER RES, V51, P2515